A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Theken Companies Acquires VisionAir Solutions

heken Companies announces its acquisition of VisionAir Solutions from Cleveland Clinic

VisionAir Solutions creates patient-specific airway stents with its 3D-design platform. VisionAir 3D Patient-Specific Stents provide improved stent life, increased time between interventions, and reduced complications for an improved patient quality of life.

VisionAir 3D Stents are personalized by pulmonologists using innovative cloud software (VisionAir 3D Stent Architect). With this unique software a physician simply uploads a patient’s scans and receives a personalized silicone stent within days that fits the patient’s specific anatomy near to perfect. This allows physicians to tailor a 3D Stent to each patient’s unique anatomy to reduce complications caused by poorly-fitting stock silicone stents. Instead of an average stock stent life of 60 days, these patient-specific stents have an average life of years, although the VisionAir stent is clinically approved by the FDA for one year. To see how simple the process is, view the video here

VisionAir stents have broad indications for the treatment of symptomatic central airway obstruction (CAO) in mature individuals that are 22 years of age or older. 3D Stents may be implanted in any location in the airway that a physician can reach with a rigid bronchoscope for implantation. This means that the 3D Stent is unique in that it can be designed to fit carinas distal to the main carina, while current traditional silicone Y-stents have stock diameters, angles, and lengths specifically designed for only the main carina.

Randy Theken, Founder of Theken Companies, said of the acquisition, “I was truly overwhelmed by the technology created by the VisionAir team at Cleveland Clinic. The VisionAir 3D Patient-Specific Stents provide significantly improved stent life and an improved patient quality of life. This is exciting not only for the pulmonary field, but for the potential to apply this technology to other medical devices.”

Thomas Gildea, MD, FCCP, FACP, of Cleveland Clinic and Inventor and Head of the Clinical Advisory Team at VisionAir Solutions, stated, “We are excited to collaborate with Randy Theken and the new VisionAir team. They continue to share our vision of bringing innovative technology to as many patients as possible.” Cleveland Clinic has an equity interest in VisionAir and is entitled to royalty payments and other commercialization revenues from the company for technology developed at Cleveland Clinic. VisionAir is the developer and manufacturer of the stents. Dr. Gildea and others at Cleveland Clinic are inventors and are entitled to royalty payments and other commercialization revenues from the company in accordance with Cleveland Clinic policy.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The acquisition of Shockwave further extends Johnson & Johnson MedTech’s position in cardiovascular intervention and accelerates its shift into higher-growth markets.
“The acquisition of Empelvic reinforces our commitment to comprehensive health solutions for intimate conditions,” said Adam Mumford, Director of Medical Devices at Owen Mumford. “By combining Owen Mumford's global expertise with Empelvic's innovative product, we aim to provide enhanced support and choices for individuals seeking pelvic health solutions.”
"The acquisition of Beyond HME represents a pivotal moment for ACU-Serve as we continue to pursue strategic growth opportunities in the healthcare sector," said Jim Knight, President of ACU-Serve. "Beyond HME's reputation for excellence and its focus on re-supply services complement our existing offerings, positioning us for even greater success in meeting the evolving needs of our clients."
Avant Technologies CEO Timothy Lantz: “We are excited about this opportunity to accelerate Avant’s growth within the healthcare sector and create new value for our customers and shareholders. This acquisition will serve to further strengthen our financial position, unlock new growth opportunities in one of the top segments of AI adoption, and bolster our internal product development and client services capabilities.”
"Thanks to the nature of software, our platform can distribute new, advanced and validated digital diagnostics to the market globally with unprecedented speed," said Linus Health CEO and Co-Founder David Bates, PhD. "As with any chronic illness, earlier detection of brain-related disabilities allows for intervention that can delay, modify or even prevent progression of the disease. It's why we are engineering the most inclusive approach to assessing and monitoring brain function, one that includes speech and movement, in addition to memory and other neurological functions."

By using this website you agree to accept Medical Device News Magazine Privacy Policy